143 results about "Behenic acid" patented technology

Disclosed herein are oxygen scavenging compositions and packaging articles that comprise (a) a metal catalyzed oxidizable compound and (b) at least one of a transition metal carboxylate, wherein the transition metal carboxylate comprises at least one carboxylate group and wherein each carboxylate group comprises between 20 and 30 carbon atoms, inclusive, such as cobalt behenate or cobalt arachidate.

Relatively large-sized hollow confectionery containing an expanded chocolate and having a very light texture. Namely, a hollow confectionery having a space volume of up to 100 ml. The hollow confectionery containing an expanded chocolate, which are composed of a gas-entrapped chocolate mass comprising a diglycerin fatty acid ester or a mixed oil containing an edible fat and tri-saturated fatty acid glycerides containing behenic acid, BOB seeding material or crystalline powdered BOB, and hollow confectionery filled with the gas-entrapped chocolate mass, can be obtained by expanding the expanded chocolate mass in the hollow confectionery under reduced pressure and then cooling to give gas-entrapped chocolate having an apparent specific gravity of 0.14 to 0.30.

The invention discloses a low-energy health chocolate and an industrial production method thereof. The chocolate comprises the following materials by weight percent: 5-10 percent of flavor component, 8-10 percent of cocoa butter, 20-30 percent of low-energy cocoa butter, 40-50 percent of low-energy sweetener, 0.5-1.0 percent of emulsifying agent and 3-10 percent of no-energy filling agent; the low-energy cocoa butter can be prepared by the following method: under the condition of 60-80 DEG C, adding caprylic acid or decylic acid and behenic acid into the cocoa butter, adding lipase with the mass equal to that of total substrate, under the stirring speed of 100-200r/min, reacting for 6-12 hours under the action of enzymatic and catalytic ester exchange, filtering to remove enzyme and obtain crude oil, and carrying out molecular distillation, refining and deacidification on the crude oil to obtain the low-energy cocoa butter; and the preparation method comprises the steps of mixing, accurate grinding, refining, temperature adjusting, forming and the like. The low-energy health chocolate realizes sugar free, low sweetness, high fibrosis and low energy.

A cleaning composition comprises at least one plant extract surfactant with solubility on oil and at least a natural macromolecular surfactant in a mass ratio of 5-50:5-50. The plant extract surfactant comprises tea saponin, saponin extractive, Sapindus saponins, palmitic acid, stearic acid, oleic acid, linoleic acid, arachidic acid and behenic acid; and the natural macromolecular surfactant comprises fatty acid methyl ester sulfonate, FMEE, alkyl polyglycoside, polyglycerol fatty acid ester, modified oil and oleic acid. The invention also provides a wet tissue using the clean composition. The wet tissue provided by the invention is convenient to carry, easy to use and has good cleaning effect.

Disclosed is a flame-retardant polyamide composition which is excellent in mechanical properties such as toughness, and heat resistance, flame retardancy and flow ability during a reflow soldering process. In addition, this polyamide composition exhibits high thermal stability during molding. Specifically disclosed is a flame-retardant polyamide composition containing (A) 20-80% by weight of a specific polyamide resin, (B) 10-20% by weight of a metal phosphinate, (C) 0.05-1% by weight of a lithium salt, a calcium salt, a barium salt, a zinc salt or an aluminum salt of montanic acid, behenic acid or stearic acid. It is preferable that this flame-retardant polyamide composition contains no halogen flame retardant.

A foaming composition suitable for topical application, containing, in an aqueous medium, one or more fatty acid salts in an amount of at least 20% of the total weight of the composition, and at least one surfactant chosen from behenyl alcohol nonionic surfactants and behenic acid nonionic surfactants. The compositions may be in the form of creams or milks, and show very good stability even after heating to very high temperature. They may be used especially in cosmetics or dermatology, as cleansing or makeup-removing products for the skin, the scalp and/or the hair.

The invention relates to a levetiracetam slow release medicinal composite and a preparation method thereof. The tablet core of the medicinal composite is mainly composed by 55-65% of levetiracetam in weight percentage and 35-45% of non hydrophilia auxiliary material with the slow release function in weight percentage, the non hydrophilia auxiliary material with the slow release function is mixed by one, two or three of ethyl cellulose, methyl cellulose or behenic acid glyceride, and the slow release medicinal composite does not need a functional controlled release coating to adjust the drug release. The levetiracetam medicinal composite has stable drug release performance, good biocompatibility and dissolution performance; and the preparation technology is simple, is easy to reproduce, and is applicable to industrialization production.

A vegetable fat composition comprises glycerides, wherein the triglyceride content of the composition is:

• • 6 to 20% SSS,
  • 5 to less than 20% SUS
  • 5 to less than 25% SSU
  • 10 to 39% SU₂ and
  • at least 20% U₃,

wherein S is a saturated fatty acid residue having 16 to 24 carbon atoms and U is an unsaturated fatty acid residue having at least 18 carbon atoms and all percentages are by weight based on the total triglycerides present in the composition,

the weight ratio SUS/SSU is between 0.5 and 2.0,

the weight ratio of (saturated fatty acid residues having 18 to 24 carbon atoms)/(saturated fatty acid residues having 16 carbon atoms) in the total S content of the triglycerides is less than 0.2,

and the triglycerides contain less than 3% of arachidic and behenic acid residues based on the total fatty acid residue content of the triglycerides,

and wherein the saturated fatty acid residue content of the triglycerides is less than 45% by weight of the total fatty acid residues in the triglycerides. The composition may be used to produce baked products and iced confectionery products.

The present invention relates to the use of fully esterified di- or oligosaccharide polyesters in hair styling products selected from hair styling waxes, hair styling creams, hair styling foam wax products, and hair styling spray wax products. Preferred saccharide polyesters are octaesters of sucrose and C8 to C30 fatty acids such as behenic acid and fatty acids derived from cotton seed oil.

[Object] To provide lip cosmetics which are excellent in the sense of use such as smoothness and adhesion upon application, excellent in moisturizing and protecting properties for lips, and excellent in long-term stability.

[Solving Means] A lip cosmetic of the present invention contains the following ingredients (a) to (e): (a) an oligomer produced from behenic acid, eicosane diacid, and a glycerin condensate; (b) a polyol; (c) water; (d) an ester oil composed of a carboxylic acid having 2 to 36 carbon atoms and an alcohol having 1 to 36 carbon atoms and being in a liquid or paste form at ordinary temperature; and (e) an oily gelling agent.

The invention relates to a reduced calorie fat and a process for the preparation of a reduced calorie fat, which includes esterification of edible oils with a source of behenic acid in the presence of a catalyst at a temperature in the range of about 25° C. to 150° C. for at least about 0.5 hours, and then recovering and purifying the reduced calorie fat using conventional methods.

The invention provides a crystallization aid. The crystallization aid is a glyceride composition; and in the glyceride composition, palmitic acid accounting for 3-40wt% of the content of total fatty acids, stearic acid accounts for 30-55wt% of the content of total fatty acids, and behenic acid accounts for 20-45wt% of the content of total fatty acids. The invention also provides a fat fractionation method. Fat crystallization is effectively promoted by combining the crystallization aid with the fractionation method, so the crystallization time is shortened, and the crystallization aid can be recycled.

The invention provides a moisture-proof coating method used for traditional Chinese medicine salvia miltiorrhiza extract powder or particles. According to the moisture-proof coating method used for the traditional Chinese medicine salvia miltiorrhiza extract powder or the particles, the traditional Chinese medicine salvia miltiorrhiza extract powder is placed in a top-spraying type fluid-bed coating machine and is prepared into dissociative small particles by means of 6% starch slurry; pulverization pressure is controlled to be 1.5 Pa; temperature of inlet wind is controlled to be at 50-55 DEG C; temperature of materials is controlled at 45-47 DEG C; after the traditional Chinese medicine salvia miltiorrhiza extract powder is prepared into dissociative the small particles by means of the 6% starch slurry and a spraying nozzle system capable of containing two layer of the small particles is installed to serve as a spraying gun device, coating materials (glycerol palmitic acid stearate or behenic acid glyceride) are heated to 55-78 DEG C; after hot air at the temperature of 55-60 DEG C is infused and the materials to be coated are fused, the temperature of the hot air and the materials reach to 66-78 DEG C; and then coating liquid is sprayed; after the coating liquid is sprayed, heating is stopped, and the materials to be coated are taken out when cooled to the temperature of 30-35 DEG C through blowing cold wind at the temperature of 30 DEG C. Products obtained with the method are good in moisture-proof effect, simple in process, small in coating amount, and high in industrial application value.

The invention provides a compound antibacterial agent and a preparation method thereof. The compound antibacterial agent contains the following components in parts by weight: 111 parts of water, 0.5-11 parts of soybean extractive solution, 0.5-2.5 parts of glycine, 0.005-3.0 parts of epsilon-poly-lysine, 0.1-5.0 parts of benzalkonium chloride, 0.01-0.1 part of ergosterol, 0.1-1 part of docosanoic acid, and 0.1-6.0 parts of didecyldimethylammonium chloride. The preparation method of the compound antibacterial agent comprises the steps of diluting soybean extractive solution with water, and proportionally adding glycine, epsilon-poly-lysine, benzalkonium chloride and didecyldimethylammonium chloride. The compound antibacterial agent provided by the invention is not harmful to human and livestock, has high sterilizing capacity, can be used at various sterilizing and disinfecting sites, and has the advantages of low cost, wide application range and good sterilizing effect.

The invention discloses separated peanut beta-ketoacyl-CoA synthase (KCS) genes AhyA.KCS1 (SEQ ID No. 2) and AhyB.KCS1 (SEQ ID No. 4). The invention also provides a method for producing transgenic yeast and plants by using the genes; the method can increase the content of very long chain fatty acids, especially behenic acid, in the plants, and the highest content reaches 12.3%; the total amount ofVLCFA in the yeast is increased to 6.1% from 0.4%, namely, is increased by nearly 15 times; the total amount of the VLCFA in the arabidopsis transgenic plant is increased to 25.0% or above, namely, is increased by 4 times or more. The method has an important application value in the improvement of plant fatty acids and the cultivation and production of high value-added oil crops.

The invention relates to a seed soaking solution special for directly-seeded rice seeds. The seed soaking solution is prepared from, by weight, 90-120 parts of magnetic water, 1.5-2.5 parts of tea saponin, 1-2 parts of purple sweet potato anthocyanin, 1-2 parts of sodium nitrophenolate, 1.5-2.5 parts of curcumin, 4-6 parts of alanine, 3-5 parts of monopotassium phosphate, 3-5 parts of carbendazim, 1.5-2.5 parts of seaweed micro powder, 4-6 parts of water soluble potassium, 1.5-2.5 parts of sodium selenite, 1.5-2.5 parts of chelated iron, 0.4-0.6 part of behenic acid glyceride, 1-2 parts of phosphate buffer, 0.4-0.6 part of neutral protease, 1.5-2.5 parts of corn starch, 1-2 parts of fulvic acid, 1.5-2.5 parts of gibberellin, 0.4-0.6 parts of rose essential oil and 0.4-0.6 parts of potassium sorbate. The seed soaking solution is free of toxins and harm, free of residues and capable of achieving the sterilizing effect, promoting sprouting of rice and increasing the emergence rate.

Disclosed is urea formaldehyde/ alkyd woodenware half-matte top finish, comprising half-matte top finish and lacquer mate; the weight ratio of half-matte top finish and lacquer-mate during the construction is 1:0.3-0.4; wherein the half-matte top finish is composed of bean oil, or alkyd at mediate or short oil length modified from behenic acid, urea resin etherified by butanol, polycarboxylic acid dispersant, aerosol flatting agent, Tissuemat E anti-settling agent, polyether organosilicone leveling agent, aralkyl organosilicone leveling agent, non-siliceous foam killer and normal butanol; the lacquer-mate is composed of paratoluenesulfonic acid, normal butanol and thinner. The top finish is environment-friendly and energy-saving and suits the requirements in the work of lacquering woodenware. The top finish is excellent in performance and the lacquer film is of the same or even better performance than polyurethane lacquer.

The invention relates to the field of drug synthesis, and specifically relates to a preparation method of a pharmaceutic adjuvant grade Glyceryl Behenate. The method provided by the invention comprises the following steps: (1) adding behenic acid and glycerol into a reactor and thoroughly stirring; (2) directly heating for a dehydration and esterification reaction; (3) adding active carbon for decolorization, and filtering while hot; and (4) adding purified water, cooling for crystallization, centrifuging, drying and crushing to obtain the pharmaceutic adjuvant grade Glyceryl Behenate. The invention employs direct dehydration esterification of behenic acid and glycerol to prepare the Glyceryl Behenate, without addition of a catalyst as in a conventional esterification reaction, such as sulfuric acid, p-toluene sulfonic acid and solid acid; no other reaction solvent needs to be added; besides, the product is convenient for refining. The process produces little ''three wastes'', has simple operation and yield higher than 89%, and is suitable for industrial production; and the quality of the prepared Glyceryl Behenate can meet the requirements of pharmaceutic adjuvant grade.

An oralloy applied solution of silymarinum-glyceride behenate nanoparticles is prepared from silymarinum, glyceride behenate and soybean phosphatide as carrier, and poloxamer 188 and glycerine as suspending aid by solvent-fusing dispersion method and high-pressure emulsifying and homogenizing method. Its advantages are high biologic utilization rate and higher curative effect.

The present invention relates to a solid, oral pharmaceutical composition comprising naloxone, or a pharmaceutically acceptable salt thereof as the active ingredient, the composition having a delayed release of said active ingredient. The composition can comprise a matrix containing glycerol di-behenic acid esters as matrix formers, with a mass ratio of naloxone to matrix former(s) of between 1:1 and 1:10, whereby the active ingredient naloxone has a delayed release. According to the invention, in order to provide a composition suitable for a dosage covering at least twelve hours for treating opioid-induced obstipation, the composition has an in-vitro release rate of the active ingredient, measured using a vane stirrer method according to Eur. Ph. at 75 U/min in 500 ml of 0.1 N hydrochloric acid at 37 DEG C, of 0 % to 75 % in 2 h, 3 % to 95 % in 4 h, 20 % to 100 % in 10 h, 30 % to 100 % in 16 h, 50 % to 100 % in 24 h and more than 80 % in 36 h, said composition having an IC50/Cmax value of at least 40. Preferably, the composition comprises a value for tmax (naloxone) / tmax (naloxone-3-glucuronoid) of at least 5. In an alternative embodiment, the composition can take the form of a multi-layer tablet.